U.S. markets open in 7 hours 13 minutes

FUJIFILM Holdings Corporation (FUJIY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
54.98-0.77 (-1.38%)
At close: 03:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close55.75
Bid0.00 x 0
Ask0.00 x 0
Day's Range54.91 - 55.23
52 Week Range50.52 - 91.87
Avg. Volume40,132
Market Cap22.099B
Beta (5Y Monthly)0.23
PE Ratio (TTM)14.10
EPS (TTM)3.90
Earnings DateN/A
Forward Dividend & Yield0.89 (1.59%)
Ex-Dividend DateMar 29, 2022
1y Target Est64.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for FUJIY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: HP Inc.HP Incorporated is a leading provider of computers, printers, and printer supplies. The company’s mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
    Fair Value
    Economic Moat
    last monthMorningstar
View more
  • Zacks

    FUJIFILM's (FUJIY) Q4 Earnings Decline Y/Y, Revenues Increase

    FUJIFILM's (FUJIY) Q4 performance benefits from strength across the Healthcare, Materials and Imaging Solutions segments.

  • Zacks

    FUJIFILM's (FUJIY) Q3 Earnings and Revenues Increase Y/Y

    FUJIFILM's (FUJIY) Q3 performance benefits from strength across the Healthcare, Materials and Imaging Solutions segments.

  • Benzinga

    Fujifilm To Buy Cell Therapy Plant From Atara For $100M

    FUJIFILM Diosynth Biotechnologies, a subsidiary of FUJIFILM Corporation, will acquire a cell therapy plant from Atara Biotherapeutics Inc (NASDAQ: ATRA) for 0 million. According to the company, the 90,000-square-foot facility in Thousand Oaks, California, is "readily expandable" and has the flexibility to produce clinical and commercial treatments, including allogenic T-cell and CAR-T immunotherapies. As part of the deal, Fujifilm Diosynth, will begin a long-term manufacturing agreement to help